American Association of Blood Banks (AABB) Virtual Annual Meeting
October 4, 2020
Session: Plenary Oral Abstract Session Title: CID-103, an Anti-CD38 Monoclonal Antibody Demonstrates Decreased RBC Binding and Decreased Interference with Pretransfusion Test Methods Poster Number: P-IG-9 Date/Time: Sunday, Oct. 4 from 1:15-2:15pm ET
You May Also Like
CASI Pharmaceuticals to Report Third Quarter 2024 Financial Results.
CASI Pharmaceuticals Announces Second Quarter 2024 Business and Financial Results
CASI Pharmaceuticals Announces First Quarter 2024 Business and Financial Results